Medtronic plc MDT has shared late-breaking clinical trial results for its PulseSelect Pulsed Field Ablation (“PFA”) system, demonstrating a high rate of durable lesion formation in treating atrial ...
Medtronic plc MDT reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of $1.26, which rose 2.4% from the year-ago quarter’s figure and beat the Zacks Consensus Estimate by 2.4%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results